Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012

In the first quarter of 2012, publicly traded companies in the cell-based therapy industry continued to show promising overall growth. Highlights included $85 million in new capital investment and steady clinical trial progress.

Click here to download the full report

Erik Miljan believes that the actual value is several fold higher, find out more at our 3 day Stem Cells course. Understand different types of stem cells, the mode of action of stem cells and impact of recent advances on the commercial market.

Leave a Reply

Your email address will not be published. Required fields are marked *